𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intra-patient variability in the measurement of tardive dyskinesia

✍ Scribed by Mary Ann Richardson; Thomas J. Craig; Marc H. Branchey

Publisher
Springer
Year
1982
Tongue
English
Weight
336 KB
Volume
76
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The life expectancy of schizophrenic pat
The life expectancy of schizophrenic patients with tardive dyskinesia
✍ Toshiya Inada; Mika Koshiishi; Kimio Ohnishi; Gohei Yagi πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 544 KB

Relationships between tardive dyskinesia (TD) and the life expectancy of schizophrenic patients who suffer it were examined in two studies over a 50-month period. In a prospective study, the mortality rate was found to be higher in patients with T D than in those without. This suggests either that T

Reduced glutamate decarboxylase activity
Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia
✍ Ulf Andersson; Jan-Erik HΓ€gstrΓΆm; Edward D. Levin; Ulf Bondesson; Milan Valveriu πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 616 KB

Glutamate decarboxylase (GAD) activity was measured in the nuclei of the basal ganglia in patients with neuroleptic-induced tardive dyskinesia (TD) and controls matched for age and premortem state. In five T D patients, who all had a sudden death, a signifcant decrease in GAD activity was found in t

A pilot study of verapamil in the treatm
A pilot study of verapamil in the treatment of tardive dyskinesia
✍ Timothy G. Dinan; Claire Capstick πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

Six patients with severe and stable tardive dyskinesia were treated with verapamil, a calcium channel blocker, in doses ranging from 240 to 400 mg/day. Weekly assessments were made using the Simpson tardive dyskinesia rating scale. Neuroleptic medication was held constant during the 3-month baseline